Related Experiment Videos
Off-pump coronary bypass for patients with concomitant malignancy.
Feza Nurözler1, S Tolga Kutlu, Güngör Kücük
1Division of Cardiovascular Surgery, Central Hospital, Izmir, Turkey. fnurozler@yahoo.com
Summary
Off-pump coronary artery bypass (OPCAB) is effective for patients with cancer, serving as a crucial bridge to necessary non-cardiac surgery. This procedure demonstrates good mid-term survival and low cardiac event rates.
Area of Science:
- Cardiovascular Surgery
- Oncology
- Surgical Outcomes
Background:
- Off-pump coronary artery bypass (OPCAB) is a surgical technique for coronary artery disease.
- Patients with cancer often have complex medical needs requiring multidisciplinary care.
- The safety and efficacy of OPCAB in patients with concurrent malignancies require evaluation.
Purpose of the Study:
- To analyze the effectiveness and advantages of OPCAB in patients with concomitant malignant neoplastic disorders.
- To assess the feasibility of OPCAB as a bridge to non-cardiac surgery in this patient population.
Main Methods:
- Retrospective analysis of 368 patients undergoing OPCAB.
- Inclusion of 18 patients with concomitant malignant neoplastic disease.
- Evaluation of perioperative data, length of hospital stay, and mid-term follow-up outcomes.
Main Results:
- No postoperative infection or in-hospital mortality observed.
- Mean length of hospital stay was 6.4 days.
- Mid-term survival was 83.4%, with 92.3% freedom from late cardiac events requiring admission.
Conclusions:
- OPCAB is an effective procedure for patients with concurrent malignancies.
- OPCAB facilitates safe and timely non-cardiac surgery, crucial for long-term survival.
- The study supports OPCAB as a valuable option for selected cancer patients with coronary artery disease.